Universal-Beteiligungs- und Servicegesellschaft’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$116M Buy
4,127,247
+80,153
+2% +$2.13M 0.2% 94
2025
Q4
$101M Sell
4,047,094
-304,709
-7% -$7.68M 0.16% 105
2025
Q3
$111M Buy
4,351,803
+29,227
+0.7% +$721K 0.18% 106
2025
Q2
$105M Buy
4,322,576
+100,751
+2% +$2.35M 0.19% 106
2025
Q1
$107M Buy
4,221,825
+81,899
+2% +$2.14M 0.21% 96
2024
Q4
$110M Buy
+4,139,926
New +$112M 0.22% 91

Other funds holding PFE

Universal-Beteiligungs- und Servicegesellschaft's PFE Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Pfizer (PFE) stake by 2% in Q1 2026, buying an estimated $2.13M and bringing the position to 4,127,247 shares worth $116M. The position accounts for 0.2% of the portfolio, ranked #94.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 4,127,247 shares of Pfizer worth $116M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 80,153 Pfizer shares in Q1 2026, an estimated $2.13M.
  • Pfizer made up 0.2% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #94 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.